Deferoxamine derivatives as medicaments
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F86652036%3A_____%2F21%3A00557146" target="_blank" >RIV/86652036:_____/21:00557146 - isvavai.cz</a>
Result on the web
<a href="https://worldwide.espacenet.com/patent/search/family/059363022/publication/EP3655414B1?q=pn%3DEP3655414B1" target="_blank" >https://worldwide.espacenet.com/patent/search/family/059363022/publication/EP3655414B1?q=pn%3DEP3655414B1</a>
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Deferoxamine derivatives as medicaments
Original language description
The deferoxamine derivatives of general formula I and pharmaceutically acceptable salts thereof, at least one of R1 and R2 is a substituent of formula II. The novel derivatives are particularly suitable as medicaments, preferably for the treatment of cancer. Pharmaceutical preparations of compounds of formula I and a metal, preferably gallium, are also provided resulting in even more active medicaments or contrast agents. Combinations with other agents, resulting in synergistic effects are provided.
Czech name
—
Czech description
—
Classification
Type
P - Patent
CEP classification
—
OECD FORD branch
10608 - Biochemistry and molecular biology
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2021
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Patent/design ID
EP 3655414
Publisher
EPO_1 -
Publisher name
European Patent Office
Place of publication
Munich, The Hague, Berlin, Vienna, Brussels
Publication country
—
Date of acceptance
Aug 25, 2021
Owner name
BIOTECHNOLOGICKÝ ÚSTAV AV ČR, v. v. i. SMART BRAIN, s.r.o.
Method of use
A - Výsledek využívá pouze poskytovatel
Usage type
A - K využití výsledku jiným subjektem je vždy nutné nabytí licence